TIFFANY POLO: Open Payments
NPI 1548640873 · KING WILLIAM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,379 in 69 payments from 20 companies in 2025. Trend: 2023 $238 · 2024 $602 · 2025 $1,379
Food & beverage: $1,360Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $242 |
| PFIZER INC. | 8 | $159 |
| AstraZeneca Pharmaceuticals LP | 8 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $144 |
| Lilly USA, LLC | 8 | $126 |
| GlaxoSmithKline, LLC. | 6 | $115 |
| Alkermes, Inc. | 1 | $108 |
| United Therapeutics Corporation | 2 | $43 |
| Novo Nordisk Inc | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
Products named: GLASSIA, NURTEC ODT, NUCALA, QULIPTA, LYBALVI, MOUNJARO, AIRSUPRA, JARDIANCE.
Industry payments across VA — which companies pay providers there.
